title: Johnson & Johnson in Talks to Buy Protagonist Therapeutics
source: Yahoo
date: 2025-10-10
url: https://finnhub.io/api/news?id=07453f6700b3ef158df7aab4a7e8246c98556559b515b385465743110cb5669d
Johnson & Johnson  is in talks to buy  Protagonist Therapeutics  in a deal that would solidify the companies’ existing partnership, according to people familiar with the matter.  A deal is not guaranteed and the exact details being discussed couldn’t be learned, the people said.  Protagonist had a market value of over $4 billion as of Thursday’s close.
